Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole Exome Sequencing to Identify Genetic Predisposition to Atypical Femoral Fractures in Women Using Bisphosphonates for Osteoporosis

NCT02731040 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02731040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02731040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole Exome Sequencing to Identify Genetic Predisposition to Atypical Femoral Fractures in Women Using Bisphosphonates for Osteoporosis
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Completed
Start date
April 30, 2016
Completion date
March 29, 2018
Enrollment
38 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atypical femoral fractures, bisphosphonate therapy, osteoporosis